company tower banner
Frau Pharma Company Logo

Frau Pharma Carfilzomib

Frau Pharma Carfilzomib is approved for the treatment of multiple myleoma, a plasma cell cancer, often in combination with other medicines with a similar therapeutic effect.

Benefit Claims (Health): Anti-Cancer Properties, Stimulates Immune System

Enhanced TDS

Enhanced TDS

Knowde-enriched technical product data sheet

Identification & Functionality

Food Ingredients Functions
Pharma & Nutraceuticals Functions

Features & Benefits

Applications & Uses

Uses

It is used to treat patients with relapsed or refractory multiple myeloma who have received one to three previous treatments.